Coherus Oncology, Inc. Liquidation Value

CHRS Other

Cash & Equivalents

$88.88M
As of 2025-12-31
Current Price: N/A

Key Metrics

Cash Liquidation Value

Cash minus Total Obligations
Cash: $88.88M
Total Obligations: -$143.67M
$-54.79M
Per share: $-0.45
Period: 2025-12-31

Liquid Liquidation Value

Cash + AR minus Total Obligations
Cash: $88.88M
AR: $17.82M
Total Obligations: -$143.67M
$-36.98M
Per share: $-0.31
Period: 2025-12-31

Operating Liquidation Value

Cash + AR + Inventory minus Total Obligations
Cash: $88.88M
AR: $17.82M
Inventory: $3.17M
Total Obligations: -$143.67M
$-33.80M
Per share: $-0.28
Period: 2025-12-31

Build your own liquidation scenario

Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.

Open Calculator →

Liquidation Ladder

MetricTotalPer Share
Cash Liquidation Value$-54.79M$-0.45
Liquid Liquidation Value$-36.98M$-0.31
Operating Liquidation Value$-33.80M$-0.28

Key Components (as of 2025-12-31)

Cash & Equivalents$88.88M
Accounts Receivable$17.82M
Inventory$3.17M
Current Liabilities$140.39M
Long-term DebtN/A
Op. Lease Liability$3.29M
Finance LeaseN/A
Shares Outstanding121.2M

Explore all 184 XBRL tags and build your own scenario → Open Calculator

Historical

PeriodCashARInventoryAPCurr LiabLT DebtOp LeaseFin Lease
2025-12-31$88.88M$17.82M$3.17M$9.91M$140.39MN/A$3.29MN/A
2025-09-30$103.35M$9.24M$2.05M$24.89M$372.30MN/AN/AN/A
2025-06-30$216.89M$5.11M$4.51M$37.62M$263.63MN/AN/AN/A
2025-03-31$82.41M$60.49M$3.52M$40.93M$255.04MN/AN/AN/A
2024-12-31$125.99M$111.32M$4.21M$28.46M$282.98MN/A$4.98MN/A
2024-09-30$97.69M$167.56M$47.64M$21.89M$295.57MN/AN/AN/A
2024-06-30$159.24M$175.25M$62.16M$76.82M$463.00MN/AN/AN/A
2024-03-31$259.77M$251.95M$61.98M$38.29M$538.30MN/AN/AN/A

Comments

SEC Filings

PeriodFormFiledLink
2025-12-31 10-K 2026-03-09 View
2025-09-30 10-Q 2025-11-06 View
2025-06-30 10-Q 2025-08-07 View
2025-03-31 10-Q 2025-05-12 View
2024-12-31 10-K 2025-03-17 View
2024-09-30 10-Q 2024-11-06 View
2024-06-30 10-Q 2024-08-08 View
2024-03-31 10-Q 2024-05-09 View

Community Notes

Loading notes...

Questions

Loading questions...